Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Amgen’s Future Looks Brighter After Ruling Lifts Threat Of Enbrel Copycat

Mon, 08/12/2019 - 7:28am

Markets are re-assessing Amgen’s long-term value after a US judge upheld two patents relating to Amgen's blockbuster rheumatoid arthritis drug...

      Related Stories 

Finance Watch: A Rough Week To End A Bad Month For Biotech Stocks

Fri, 08/09/2019 - 3:34pm

Public Company Edition: The prior day's after-hours bad news sent biotech stocks lower on 9 August, and IPOs are taking...

      Related Stories 

Gilead’s Marketing Of Descovy For HIV Prevention Should Not Suggest Superiority To Truvada

Fri, 08/09/2019 - 1:52pm

US FDA advisory committee members urge agency to hold a firm line against labeling, promotional or educational materials that suggest...

      Related Stories 

Top 10 Drugs: Biologic Blockbusters And The Biosimilar Threat

Fri, 08/09/2019 - 7:11am

INFOGRAPHIC: maturing cancer and autoimmune biologics still top the league for global revenues, but biosimilars are snapping at their heels.  ...

      Related Stories 

Dull Q1 for Cipla Amid Distributor 'Churn' In India

Thu, 08/08/2019 - 5:19pm

A significant shake-up of distributors in the Indian market impacted Cipla’s first-quarter earnings but the firm expects to bounce back...

      Related Stories 

Opioid Exposure Risk Intensifying For Generic Drug Makers

Thu, 08/08/2019 - 12:13pm

Business fundamentals took a back seat to opioid litigation in the second quarter for generic drug makers, including Teva, Mallinckrodt...

      Related Stories 

Merck KGaA Moves MS Hopeful Evobrutinib To Phase III, Plans Pipeline Update

Thu, 08/08/2019 - 9:07am

Merck KGaA said its second-quarter performance was boosted by its Life Science lab unit and milestone payments from drug development...

      Related Stories 

Pages